Literature DB >> 12029162

Rabies virus glycoprotein can fold in two alternative, antigenically distinct conformations depending on membrane-anchor type.

Antoine P Maillard1, Yves Gaudin1.   

Abstract

Rabies virus glycoprotein (G) is a trimeric type I transmembrane glycoprotein that mediates both receptor recognition and low pH-induced membrane fusion. We have previously demonstrated that a soluble form of the ectodomain of G (G(1-439)), although secreted, is folded in an alternative conformation, which is monomeric and antigenically distinct from the native state of the complete, membrane-anchored glycoprotein. This has raised questions concerning the role of the transmembrane domain (TMD) in the correct native folding of the ectodomain. Here, we show that an ectodomain anchored in the membrane by a glycophosphatidylinositol is also folded in an alternative conformation, whereas replacement of the TMD of G by other peptide TMDs results in correct antigenicity of G. However, mutants with an insertion of a hydrophilic linker between the ectodomain and the TMD also fold in an alternative conformation. The influence of the membrane-anchor type on G ectodomain trimerization and folding is discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12029162     DOI: 10.1099/0022-1317-83-6-1465

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  7 in total

1.  Mutations conferring resistance to neutralization by a soluble form of the neurotrophin receptor (p75NTR) map outside of the known antigenic sites of the rabies virus glycoprotein.

Authors:  Christelle Langevin; Christine Tuffereau
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1.

Authors:  Penny L Moore; Emma T Crooks; Lauren Porter; Ping Zhu; Charmagne S Cayanan; Henry Grise; Paul Corcoran; Michael B Zwick; Michael Franti; Lynn Morris; Kenneth H Roux; Dennis R Burton; James M Binley
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

3.  Growth of recombinant Drosophila melanogaster Schneider 2 cells producing rabies virus glycoprotein in bioreactor employing serum-free medium.

Authors:  Adriana L L Galesi; Marcelo A Aguiar; Renato M Astray; Elisabeth F P Augusto; Angela M Moraes
Journal:  Cytotechnology       Date:  2008-03-02       Impact factor: 2.058

4.  Entry of Challenge Virus Standard (CVS) -11 into N2a cells via a clathrin-mediated, cholesterol-, dynamin-, pH-dependent endocytic pathway.

Authors:  Jie Gao; Xinyu Wang; Mingxin Zhao; Enhua Liu; Ming Duan; Zhenhong Guan; Yidi Guo; Maolin Zhang
Journal:  Virol J       Date:  2019-06-13       Impact factor: 4.099

5.  Full-length G glycoprotein directly extracted from rabies virus with detergent and then stabilized by amphipols in liquid and freeze-dried forms.

Authors:  Didier Clénet; Léna Clavier; Benoît Strobbe; Christel Le Bon; Manuela Zoonens; Aure Saulnier
Journal:  Biotechnol Bioeng       Date:  2021-08-05       Impact factor: 4.395

6.  Predicted 3D Model of the Rabies Virus Glycoprotein Trimer.

Authors:  Bastida-González Fernando; Celaya-Trejo Yersin; Correa-Basurto José; Zárate-Segura Paola
Journal:  Biomed Res Int       Date:  2016-05-04       Impact factor: 3.411

7.  Chimeric rabies glycoprotein with a transmembrane domain and cytoplasmic tail from Newcastle disease virus fusion protein incorporates into the Newcastle disease virion at reduced levels.

Authors:  Gui Mei Yu; Shu Long Zu; Wei Wei Zhou; Xi Jun Wang; Lei Shuai; Xue Lian Wang; Jin Ying Ge; Zhi Gao Bu
Journal:  J Vet Sci       Date:  2017-08-31       Impact factor: 1.672

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.